Aspiriant, LLC
- SEC CIK
- 0001433541
- Latest filing
- Jul 20, 2026
MRK holding history
Merck & Co., Inc. in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRK overviewAll 13F holders of MRKFull Q2 2026 holdings
- Shares (Q2 2026)
- 17,559
- Value
- $2.26M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 17,559 | $2.26M | 0.1% | +2,125+13.8% | Added | Holders |
| Q1 2026 | 15,434 | $1.86M | 0.1% | +251+1.7% | Added | Holders |
| Q4 2025 | 15,183 | $1.60M | <0.1% | +1,373+9.9% | Added | Holders |
| Q3 2025 | 13,810 | $1.16M | <0.1% | −2,980−17.7% | Reduced | Holders |
| Q2 2025 | 16,790 | $1.33M | <0.1% | +1,696+11.2% | Added | Holders |
| Q1 2025 | 15,094 | $1.35M | <0.1% | −178−1.2% | Reduced | Holders |
| Q4 2024 | 15,272 | $1.52M | 0.1% | −105−0.7% | Reduced | Holders |
| Q3 2024 | 15,377 | $1.75M | 0.1% | −535−3.4% | Reduced | Holders |
| Q2 2024 | 15,912 | $1.97M | 0.1% | −3,269−17.0% | Reduced | Holders |
| Q1 2024 | 19,181 | $2.53M | 0.1% | +755+4.1% | Added | Holders |
| Q4 2023 | 18,426 | $2.01M | 0.1% | +161+0.9% | Added | Holders |
| Q3 2023 | 18,265 | $1.88M | 0.1% | +1,380+8.2% | Added | Holders |
| Q2 2023 | 16,885 | $1.95M | 0.1% | −95−0.6% | Reduced | Holders |
| Q1 2023 | 16,980 | $1.81M | 0.1% | +180+1.1% | Added | Holders |
| Q4 2022 | 16,800 | $1.86M | 0.1% | −194−1.1% | Reduced | Holders |
| Q3 2022 | 16,994 | $1.46M | 0.1% | +701+4.3% | Added | Holders |
| Q2 2022 | 16,293 | $1.48M | 0.1% | −456−2.7% | Reduced | Holders |
| Q1 2022 | 16,749 | $1.37M | 0.1% | −325−1.9% | Reduced | Holders |
| Q4 2021 | 17,074 | $1.31M | 0.1% | +2,446+16.7% | Added | Holders |
| Q3 2021 | 14,628 | $1.10M | 0.1% | −181−1.2% | Reduced | Holders |
| Q2 2021 | 14,809 | $1.15M | 0.1% | +268+1.8% | Added | Holders |
| Q1 2021 | 14,541 | $1.12M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.